₹842.00 10.55 (1.27%)
04:01 PM, 22-Apr-2025₹839.30 9.50 (1.14%)
03:52 PM, 22-Apr-2025BSE : 524816
NSE : NATCOPHARM
Sector : Health care
ISIN Code : INE987B01026
Last Updated: 22-Apr-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 15,080 |
Traded Value (₹ Cr) | 1.12 |
Volume (Shares) | 13,259 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,638.35 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 660.05 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 1,638.35 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.60 |
All Time Low Date | 17-Sep-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 15,032 |
EPS - TTM (₹) [C] | 104.13 |
P/E Ratio (X) [C] | 8.06 |
Face Value (₹) | 2 |
Latest Dividend (%) | 75.00 |
Latest Dividend Date | 18-Feb-2025 |
Dividend Yield (%) | 1.13 |
Book Value Share (₹) [C] | 399.19 |
P/B Ratio (₹) [C] | 2.10 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Tata Equity P/E Fund - (G) | 135.15 | 16,92,000 | 1.69 |
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) | 135.15 | 16,92,000 | 1.69 |
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) | 135.15 | 16,92,000 | 1.69 |
Tata Equity P/E Fund - Direct (G) | 135.15 | 16,92,000 | 1.69 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) | 135.15 | 16,92,000 | 1.69 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) | 135.15 | 16,92,000 | 1.69 |
Tata Small Cap Fund - Regular (G) | 43.86 | 5,49,064 | 0.48 |
Tata Small Cap Fund - Regular (IDCW) | 43.86 | 5,49,064 | 0.48 |
Tata Small Cap Fund - Direct (G) | 43.86 | 5,49,064 | 0.48 |
Tata Small Cap Fund - Direct (IDCW) | 43.86 | 5,49,064 | 0.48 |
Load more
Today's Low/High (₹) | 825.05 843.80 |
Week Low/High (₹) | 778.65 843.80 |
Month Low/High (₹) | 726.80 856.00 |
Year Low/High (₹) | 726.80 1,639.00 |
All time Low/High (₹) | 1.60 1,639.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 4.31% | 34.87% | 3.73% | 3.60% |
1 Month | 1.20% | 30.75% | 3.50% | 3.50% |
3 Month | -33.52% | -14.14% | 4.18% | 4.37% |
6 Month | -36.81% | -18.35% | -0.78% | -1.25% |
1 Year | -16.57% | 7.82% | 8.07% | 8.20% |
3 Year | 6.77% | 38.13% | 39.16% | 40.74% |
Chairman & Managing Director : V C Nannapaneni
Vice Chairman & CEO : Rajeev Nannapaneni
Vice President & Director : PSRK Prasad
President & Director : D Linga Rao
Vice President & Director : Pavan Bhat
Company Sec. & Compli. Officer : Venkat Ramesh
Independent Director : A D Murthy Chavali
Independent Director : B. Lakshminarayana
Independent Director : Kantipudi Suma
Independent Director : Nitin Jain
Independent Director : Vijayabhaskar Dronadula
Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532
1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 842.00 at 04:01 PM IST on 22nd Apr 2025. Natco Pharma Ltd share price was up by 1.27% over the previous closing price of Rs 831.45. Natco Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 15,080 crore.
4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 660.05.
5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 132.40 crore on a total income of Rs 651.10 crore for the quarter ended 2024. For the year ended 2024, Natco Pharma Ltd had posted a profit of Rs 1,388.30 crore on a total income of Rs 3,998.80 crore.
6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Concord Biotech, Alembic Pharma, Neuland Labs., Natco Pharma, Sai Life, Sanofi India, Jubilant Pharmo.
7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows: